Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Fritsche

Showing results (101-110 of 456) with videos related to

Pageof 46
Sort By:
Obesity (Silver Spring, Md.)|April 19, 2008
11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivityKarsten Müssig, Thomas Remer, Axel Haupt, et al.
The Lancet. Diabetes & Endocrinology|May 24, 2020
Central nervous pathways of insulin action in the control of metabolism and food intakeStephanie Kullmann, André Kleinridders, Dana M Small, et al.
Journal of Applied Biomaterials & Functional Materials|April 20, 2013
Biomechanical behavior of bone scaffolds made of additive manufactured tricalciumphosphate and titanium alloy under different loading conditionsJan Wieding, Andreas Fritsche, Peter Heinl, et al.
Magma (New York, N.Y.)|January 8, 2011
Morning to evening changes of intramyocellular lipid content in dependence on nutrition and physical activity during one single day: a volume selective 1H-MRS studyJürgen Machann, Manuela Etzel, Claus Thamer, et al.
Diabetologia|October 26, 2014
Erythrocyte membrane fatty acid fluidity and risk of type 2 diabetes in the EPIC-Potsdam studyJanine Kröger, Simone Jacobs, Eugène H J M Jansen, et al.
Diabetes, Obesity & Metabolism|May 10, 2019
Predictors of treatment response in type-2 diabetes patients initiating basal-supported oral therapy with insulin glargine 100 U/mL: A sub-analysis of the Titration and OPtimisation (TOP) registryMartin Pfohl, Stefan Pscherer, Andreas Fritsche, et al.
Diabetes, Obesity & Metabolism|September 19, 2018
Titration and optimization trial for the initiation of insulin glargine 100 U/mL in patients with inadequately controlled type 2 diabetes on oral antidiabetic drugsJochen Seufert, Andreas Fritsche, Stefan Pscherer, et al.
Scientific Reports|October 5, 2021
A newly developed and externally validated non-clinical score accurately predicts 10-year cardiovascular disease risk in the general adult populationCatarina Schiborn, Tilman Kühn, Kristin Mühlenbruch, et al.
Diabetes|January 24, 2003
Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell functionRiccardo C Bonadonna, Michael Stumvoll, Andreas Fritsche, et al.
Human Brain Mapping|April 27, 2011
The obese brain: association of body mass index and insulin sensitivity with resting state network functional connectivityStephanie Kullmann, Martin Heni, Ralf Veit, et al.
Pageof 46

Showing results (101-110 of 456) with videos related to

Sort By:
Pageof 46
Obesity (Silver Spring, Md.)|April 19, 2008
11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivityKarsten Müssig, Thomas Remer, Axel Haupt, et al.
The Lancet. Diabetes & Endocrinology|May 24, 2020
Central nervous pathways of insulin action in the control of metabolism and food intakeStephanie Kullmann, André Kleinridders, Dana M Small, et al.
Journal of Applied Biomaterials & Functional Materials|April 20, 2013
Biomechanical behavior of bone scaffolds made of additive manufactured tricalciumphosphate and titanium alloy under different loading conditionsJan Wieding, Andreas Fritsche, Peter Heinl, et al.
Magma (New York, N.Y.)|January 8, 2011
Morning to evening changes of intramyocellular lipid content in dependence on nutrition and physical activity during one single day: a volume selective 1H-MRS studyJürgen Machann, Manuela Etzel, Claus Thamer, et al.
Diabetologia|October 26, 2014
Erythrocyte membrane fatty acid fluidity and risk of type 2 diabetes in the EPIC-Potsdam studyJanine Kröger, Simone Jacobs, Eugène H J M Jansen, et al.
Diabetes, Obesity & Metabolism|May 10, 2019
Predictors of treatment response in type-2 diabetes patients initiating basal-supported oral therapy with insulin glargine 100 U/mL: A sub-analysis of the Titration and OPtimisation (TOP) registryMartin Pfohl, Stefan Pscherer, Andreas Fritsche, et al.
Diabetes, Obesity & Metabolism|September 19, 2018
Titration and optimization trial for the initiation of insulin glargine 100 U/mL in patients with inadequately controlled type 2 diabetes on oral antidiabetic drugsJochen Seufert, Andreas Fritsche, Stefan Pscherer, et al.
Scientific Reports|October 5, 2021
A newly developed and externally validated non-clinical score accurately predicts 10-year cardiovascular disease risk in the general adult populationCatarina Schiborn, Tilman Kühn, Kristin Mühlenbruch, et al.
Diabetes|January 24, 2003
Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell functionRiccardo C Bonadonna, Michael Stumvoll, Andreas Fritsche, et al.
Human Brain Mapping|April 27, 2011
The obese brain: association of body mass index and insulin sensitivity with resting state network functional connectivityStephanie Kullmann, Martin Heni, Ralf Veit, et al.
Pageof 46